参考文献

 1 Reguiaz GF. The role of anti-tumor necrosis factor-alpha therapy in pyoderma gangrenosum associated with inflammatory bowel disease[J]. Am J Clin Dematol, 2007, 8:67-77.

 2 渠涛, 王宝玺. 坏疽性脓皮病25例回顾性分析[J]. 中国皮肤性病学杂志, 2004, 18:598-600.

 3 Hoffman MD. Pyoderma gangrenosum associated with c-ANCA (h-lanlp-2)[J]. Int J Dermatol, 2001, 40:135-137.

 4 Danese S, Papa A, Saibeni S, et al. Inflammation and coagulation in inflammatory bowel disease:The clot thickens[J]. Am J Gastroenterol, 2007, 102:174-186.

 5 Saposnik G, Barinagarrementeria F, Brown RD, et al. Diagnosis and management of cerebral venous thrombosis:a statement for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2011, 4:1158-92.

 6 Katsanos AH, Katsanos KH, Kosmidou M, et al. Cerebral sinus venous thrombosis in inflammatory bowel diseases[J]. QJM, 2013, 5:401-13.

 7 Crespo EM, Oliveira GB, Honeyeutt EF, et al. Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients; the complications after thrombocytopenia caused by heparin (CATCH) registry[J]. Am Heart J, 2009, 157, 651-657.

(收稿日期：2014-03-28)